REPLIGEN CORP Shares Outstanding (Cover Page)
REPLIGEN CORP (RGEN) had Shares Outstanding (Cover Page) of 56.44 million shares as of 2026-07-24, per its 10-Q filed 2026-07-29.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-07-29
- 2026-07-24: Entity Common Stock, Shares Outstanding 56.44M shares.
- 2026-05-01: Entity Common Stock, Shares Outstanding 56.41M shares.
- 2026-02-20: Entity Common Stock, Shares Outstanding 56.33M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 56.29M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-24 | 56.44M shares 10-Q · filed 2026-07-29 |
| 2026-05-01 | 56.41M shares 10-Q · filed 2026-05-06 |
| 2026-02-20 | 56.33M shares 10-K · filed 2026-02-26 |
| 2025-10-31 | 56.29M shares 10-Q · filed 2025-11-04 |
| 2025-08-04 | 56.26M shares 10-Q · filed 2025-08-07 |
| 2025-04-25 | 56.18M shares 10-Q · filed 2025-04-29 |
| 2025-03-11 | 56.15M shares 10-K · filed 2025-03-14 |
| 2024-11-12 | 56.03M shares 10-Q · filed 2024-11-18 |
| 2024-07-26 | 56.01M shares 10-Q/A · filed 2024-11-18 |
| 2024-04-29 | 55.88M shares 10-Q/A · filed 2024-11-18 |
| 2024-02-16 | 55.77M shares 10-K/A · filed 2024-11-18 |
| 2023-10-27 | 55.83M shares 10-Q/A · filed 2024-11-18 |
| 2023-07-31 | 55.76M shares 10-Q/A · filed 2024-11-18 |
| 2023-04-28 | 55.68M shares 10-Q/A · filed 2024-11-18 |
| 2023-02-17 | 55.56M shares 10-K · filed 2023-02-22 |
| 2022-10-28 | 55.52M shares 10-Q · filed 2022-11-01 |
| 2022-07-29 | 55.49M shares 10-Q · filed 2022-08-02 |
| 2022-04-25 | 55.43M shares 10-Q · filed 2022-04-27 |
| 2022-02-14 | 55.33M shares 10-K · filed 2022-02-17 |
| 2021-10-25 | 55.29M shares 10-Q · filed 2021-10-28 |
| 2021-07-23 | 54.98M shares 10-Q · filed 2021-07-27 |
| 2021-04-30 | 54.90M shares 10-Q · filed 2021-05-04 |
| 2021-02-19 | 54.77M shares 10-K · filed 2021-02-24 |
| 2020-11-02 | 52.62M shares 10-Q · filed 2020-11-05 |
| 2020-07-27 | 52.50M shares 10-Q · filed 2020-07-30 |
| 2020-05-04 | 52.31M shares 10-Q · filed 2020-05-06 |
| 2020-02-18 | 52.08M shares 10-K · filed 2020-02-26 |
| 2019-10-28 | 52.06M shares 10-Q · filed 2019-10-31 |
| 2019-07-30 | 51.53M shares 10-Q · filed 2019-08-01 |
| 2019-05-03 | 47.23M shares 10-Q · filed 2019-05-09 |
| 2019-02-22 | 43.92M shares 10-K · filed 2019-03-01 |
| 2018-10-29 | 43.86M shares 10-Q · filed 2018-11-01 |
| 2018-07-26 | 43.81M shares 10-Q · filed 2018-08-02 |
| 2018-05-01 | 43.69M shares 10-Q · filed 2018-05-08 |
| 2018-02-15 | 43.59M shares 10-K · filed 2018-02-22 |
| 2017-11-02 | 43.57M shares 10-Q · filed 2017-11-09 |
| 2017-07-28 | 37.36M shares 10-Q · filed 2017-08-03 |
| 2017-04-28 | 34.08M shares 10-Q · filed 2017-05-04 |
| 2017-02-17 | 33.85M shares 10-K · filed 2017-02-23 |
| 2016-10-28 | 33.83M shares 10-Q · filed 2016-11-03 |
| 2016-07-29 | 33.79M shares 10-Q · filed 2016-08-04 |
| 2016-04-29 | 33.64M shares 10-Q · filed 2016-05-05 |
| 2016-02-18 | 33.03M shares 10-K · filed 2016-02-25 |
| 2015-10-29 | 32.94M shares 10-Q · filed 2015-11-05 |
| 2015-07-31 | 32.91M shares 10-Q · filed 2015-08-06 |
| 2015-05-01 | 32.85M shares 10-Q · filed 2015-05-08 |
| 2015-03-12 | 32.78M shares 10-K · filed 2015-03-17 |
| 2014-10-16 | 32.72M shares 10-Q · filed 2014-11-07 |
| 2014-07-10 | 32.65M shares 10-Q · filed 2014-08-11 |
| 2014-04-14 | 32.04M shares 10-Q · filed 2014-05-09 |
| 2014-02-12 | 31.94M shares 10-K · filed 2014-03-14 |
| 2013-10-23 | 31.91M shares 10-Q · filed 2013-11-08 |
| 2013-07-29 | 31.82M shares 10-Q · filed 2013-08-07 |
| 2013-04-19 | 31.44M shares 10-Q · filed 2013-05-07 |
| 2013-02-20 | 31.22M shares 10-K · filed 2013-03-15 |
| 2012-10-30 | 31.11M shares 10-Q · filed 2012-11-08 |
| 2012-07-30 | 30.94M shares 10-Q · filed 2012-08-09 |
| 2012-04-30 | 30.85M shares 10-Q · filed 2012-05-10 |
| 2012-03-06 | 30.72M shares 10-K · filed 2012-03-15 |
| 2011-10-31 | 30.71M shares 10-Q · filed 2011-11-09 |
| 2011-08-02 | 30.81M shares 10-Q · filed 2011-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |